Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pascal Soriot
Pharma
AZ leans on cancer, rare disease muscle in solid Q2
In 2026’s second quarter, AstraZeneca generated revenue of nearly $15.4 million, growing 5% over the same period in 2025 at constant currencies.
Fraiser Kansteiner
Jul 27, 2026 10:21am
AstraZeneca CEO outlines conservative forecast model for MFN
Apr 29, 2026 3:08pm
AZ CEO pay hits $23.9M amid serious 'geopolitical uncertainty’
Feb 24, 2026 11:35am
AZ sets sights on 25+ blockbusters by 2030
Feb 10, 2026 11:20am
AZ will spend $2B to bolster manufacturing presence in Maryland
Nov 21, 2025 3:58pm
AZ CEO: 'We can absorb the impact' of US drug pricing deal
Nov 6, 2025 10:40am
